Health and Medicine
Oct. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.
New faculty: Tuya Pal, associate professor of medicine and Ingram Associate Professor of Cancer Research
Oct. 26, 2017—A high school science class discussion about how genetic traits are passed down from one generation to another inspired Tuya Pal to pursue a career in clinical genetics. Pal is a physician who specializes in cancer health disparities among diverse populations.
Oct. 23, 2017—Renã A. S. Robinson’s interest in aging dates back to her childhood. Her mother spent her spare time as a caregiver attending to elderly people with dementia. Now an analytic chemist, Robinson is investigating the science behind this very human condition. She is employing the emerging field of proteomics to study the process of aging as well as neurodegenerative diseases like Alzheimer’s.
Oct. 23, 2017—Erin Calipari could be described as a code breaker. Using technologies that allow her to probe the activity of single neurons in awake and behaving animals, she is piecing together the neural code that controls motivation and decision-making.
Oct. 19, 2017—Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving.
Oct. 16, 2017—Four to five drinks in an evening. Starting the weekend on Thursday with happy hour. No big deal, right? Wrong, according to Mariann Piano, whose work indicates that binge drinking by young adults 18-30 may lead to vascular dysfunction and increased vulnerability to cardiovascular disease.
Oct. 12, 2017—Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith's research could fundamentally change allergy treatment.
Oct. 12, 2017—Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.